ONCAlert | Upfront Therapy for mRCC
Publications  >  Special Reports  >  2014  >  NSCLC (Issue 2)  >  

Crizotinib Resistance in ALK-Positive Lung Cancer

Alice T. Shaw, MD, PhD
Published Online: Feb 26,2014
Alice T. Shaw, MD, PhD, an attending physician in the Center for Thoracic Cancers at Massachusetts General Hospital, discusses resistance to crizotinib in patients with ALK-positive lung cancer.

Learn more about the treatment of ALK-positive lung cancer > >


Clinical Articles

Crizotinib Resistance in ALK-Positive Lung Cancer
Copyright © TargetedOnc 2019 Intellisphere, LLC. All Rights Reserved.